OpenAlex
PricingAboutJobs
Log inGet started
Work

Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3 H -imidazo[4,5- b ]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor

HTML

Year: 2016
Type: article
Source: Journal of Medicinal Chemistry
DOI: 10.1021/acs.jmedchem.6b00619
Authors: Jean-Marc Lapierre, Sudharshan Eathiraj, David Vensel, Yanbin Liu, Cathy O. Bull, Susan Cornell-Kennon, Shin Iimura, Eugene W. Kelleher, Darin E. Kizer, Steffi Koerner, Sapna Makhija, Akihisa Matsuda, Magdi Moussa, Nivedita Namdev, Ronald E. Savage, Jeff Szwaya, Erika Volckova, Neil Westlund, Hui Wu, Brian Schwartz
Institutions: Arqule (United States), Daiichi-Sankyo (Japan)
Language: English

Topic: PI3K/AKT/mTOR signaling in cancer
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: allosteric AKT inhibitor, AKT1, AKT2, AKT3, cyclobutylamine, co-crystal structure, PRAS40 phosphorylation, endometrial adenocarcinoma, oral bioavailability, kinase inhibitor discovery
SDG: Good health and well-being

Open Access status: closed

Funder: National Institute of General Medical Sciences
Award: Life Science and Biomedical technology Research center at NSLS-II LSBR
OpenAlex ID: W2421665744
FWCI: 2.904
Cites: 20
Cited by: 136
Related to: 10
Parts: 1
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security